obesity-995x60.png
FEATURED ARTICLES
When To Build Out Your ClinOps Team — And Other Advice For First-Time Biotechs
Small biotechs shouldn't model their ClinOps headcount after Big Pharma. Instead, they need the right capabilities, oversight, and risk controls. Consultant Jessica Cordes explains.
-
Ossium's Unconventional Site Strategy For Studying A Novel Bone Marrow Donor Source
Ossium CEO Kevin Caldwell explains how an unconventional multisite Phase 1 trial is shaping the company's novel bone marrow product’s path ahead.
-
Who Owns Your Clinical Trial Software When The Vendor Leaves?
When a clinical trial software vendor exits, sponsors still own the risk. Learn what to secure before signing a contract to protect data, validation, and continuity.
-
Beyond RAG: Why Life Sciences AI Workflows Need Better Context, Not Just Better Models
Teams want AI systems that can answer complex scientific questions across value chain, but as these systems move closer to production, a recurring problem is becoming visible.